Global Antisense Oligonucleotides (ASO) Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 66

Published Date: 14 May 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases
According to our (Global Info Research) latest study, the global Antisense Oligonucleotides (ASO) Therapy market size was valued at US$ 3694 million in 2023 and is forecast to a readjusted size of USD 10580 million by 2030 with a CAGR of 16.9% during review period.

This report is a detailed and comprehensive analysis for global Antisense Oligonucleotides (ASO) Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Antisense Oligonucleotides (ASO) Therapy market size and forecasts, in consumption value ($ Million), 2019-2030
Global Antisense Oligonucleotides (ASO) Therapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Antisense Oligonucleotides (ASO) Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Antisense Oligonucleotides (ASO) Therapy market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antisense Oligonucleotides (ASO) Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antisense Oligonucleotides (ASO) Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Antisense Oligonucleotides (ASO) Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Antisense Oligonucleotides (ASO) Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Intrathecal Injection
    Intravenous Injections
    Other

Market segment by Application
    Neuromuscular Diseases
    hATTR
    Other

Market segment by players, this report covers
    Ionis Pharmaceuticals
    Biogen
    Sobi
    Nippon Shinyaku
    Jazz Pharmaceuticals

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antisense Oligonucleotides (ASO) Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antisense Oligonucleotides (ASO) Therapy, with revenue, gross margin, and global market share of Antisense Oligonucleotides (ASO) Therapy from 2019 to 2024.
Chapter 3, the Antisense Oligonucleotides (ASO) Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antisense Oligonucleotides (ASO) Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antisense Oligonucleotides (ASO) Therapy.
Chapter 13, to describe Antisense Oligonucleotides (ASO) Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Antisense Oligonucleotides (ASO) Therapy by Type
        1.3.1 Overview: Global Antisense Oligonucleotides (ASO) Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Intrathecal Injection
        1.3.4 Intravenous Injections
        1.3.5 Other
    1.4 Global Antisense Oligonucleotides (ASO) Therapy Market by Application
        1.4.1 Overview: Global Antisense Oligonucleotides (ASO) Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Neuromuscular Diseases
        1.4.3 hATTR
        1.4.4 Other
    1.5 Global Antisense Oligonucleotides (ASO) Therapy Market Size & Forecast
    1.6 Global Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast by Region
        1.6.1 Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Antisense Oligonucleotides (ASO) Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Antisense Oligonucleotides (ASO) Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Antisense Oligonucleotides (ASO) Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Antisense Oligonucleotides (ASO) Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Ionis Pharmaceuticals
        2.1.1 Ionis Pharmaceuticals Details
        2.1.2 Ionis Pharmaceuticals Major Business
        2.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product and Solutions
        2.1.4 Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Ionis Pharmaceuticals Recent Developments and Future Plans
    2.2 Biogen
        2.2.1 Biogen Details
        2.2.2 Biogen Major Business
        2.2.3 Biogen Antisense Oligonucleotides (ASO) Therapy Product and Solutions
        2.2.4 Biogen Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Biogen Recent Developments and Future Plans
    2.3 Sobi
        2.3.1 Sobi Details
        2.3.2 Sobi Major Business
        2.3.3 Sobi Antisense Oligonucleotides (ASO) Therapy Product and Solutions
        2.3.4 Sobi Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Sobi Recent Developments and Future Plans
    2.4 Nippon Shinyaku
        2.4.1 Nippon Shinyaku Details
        2.4.2 Nippon Shinyaku Major Business
        2.4.3 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product and Solutions
        2.4.4 Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Nippon Shinyaku Recent Developments and Future Plans
    2.5 Jazz Pharmaceuticals
        2.5.1 Jazz Pharmaceuticals Details
        2.5.2 Jazz Pharmaceuticals Major Business
        2.5.3 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product and Solutions
        2.5.4 Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Jazz Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Antisense Oligonucleotides (ASO) Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Antisense Oligonucleotides (ASO) Therapy by Company Revenue
        3.2.2 Top 3 Antisense Oligonucleotides (ASO) Therapy Players Market Share in 2023
        3.2.3 Top 6 Antisense Oligonucleotides (ASO) Therapy Players Market Share in 2023
    3.3 Antisense Oligonucleotides (ASO) Therapy Market: Overall Company Footprint Analysis
        3.3.1 Antisense Oligonucleotides (ASO) Therapy Market: Region Footprint
        3.3.2 Antisense Oligonucleotides (ASO) Therapy Market: Company Product Type Footprint
        3.3.3 Antisense Oligonucleotides (ASO) Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Antisense Oligonucleotides (ASO) Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Antisense Oligonucleotides (ASO) Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Antisense Oligonucleotides (ASO) Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2030)
    6.2 North America Antisense Oligonucleotides (ASO) Therapy Market Size by Application (2019-2030)
    6.3 North America Antisense Oligonucleotides (ASO) Therapy Market Size by Country
        6.3.1 North America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Antisense Oligonucleotides (ASO) Therapy Market Size by Country
        7.3.1 Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Market Size by Region
        8.3.1 Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2030)
    9.2 South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2030)
    9.3 South America Antisense Oligonucleotides (ASO) Therapy Market Size by Country
        9.3.1 South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Market Size by Country
        10.3.1 Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Antisense Oligonucleotides (ASO) Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Antisense Oligonucleotides (ASO) Therapy Market Drivers
    11.2 Antisense Oligonucleotides (ASO) Therapy Market Restraints
    11.3 Antisense Oligonucleotides (ASO) Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Antisense Oligonucleotides (ASO) Therapy Industry Chain
    12.2 Antisense Oligonucleotides (ASO) Therapy Upstream Analysis
    12.3 Antisense Oligonucleotides (ASO) Therapy Midstream Analysis
    12.4 Antisense Oligonucleotides (ASO) Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Ionis Pharmaceuticals Company Information, Head Office, and Major Competitors
 Table 6. Ionis Pharmaceuticals Major Business
 Table 7. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product and Solutions
 Table 8. Ionis Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Ionis Pharmaceuticals Recent Developments and Future Plans
 Table 10. Biogen Company Information, Head Office, and Major Competitors
 Table 11. Biogen Major Business
 Table 12. Biogen Antisense Oligonucleotides (ASO) Therapy Product and Solutions
 Table 13. Biogen Antisense Oligonucleotides (ASO) Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Biogen Recent Developments and Future Plans
 Table 15. Sobi Company Information, Head Office, and Major Competitors
 Table 16. Sobi Major Business
 Table 17. Sobi Antisense Oligonucleotides (ASO) Therapy Product and Solutions
 Table 18. Sobi Antisense Oligonucleotides (ASO) Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Nippon Shinyaku Company Information, Head Office, and Major Competitors
 Table 20. Nippon Shinyaku Major Business
 Table 21. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Product and Solutions
 Table 22. Nippon Shinyaku Antisense Oligonucleotides (ASO) Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Nippon Shinyaku Recent Developments and Future Plans
 Table 24. Jazz Pharmaceuticals Company Information, Head Office, and Major Competitors
 Table 25. Jazz Pharmaceuticals Major Business
 Table 26. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Product and Solutions
 Table 27. Jazz Pharmaceuticals Antisense Oligonucleotides (ASO) Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Jazz Pharmaceuticals Recent Developments and Future Plans
 Table 29. Global Antisense Oligonucleotides (ASO) Therapy Revenue (USD Million) by Players (2019-2024)
 Table 30. Global Antisense Oligonucleotides (ASO) Therapy Revenue Share by Players (2019-2024)
 Table 31. Breakdown of Antisense Oligonucleotides (ASO) Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 32. Market Position of Players in Antisense Oligonucleotides (ASO) Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 33. Head Office of Key Antisense Oligonucleotides (ASO) Therapy Players
 Table 34. Antisense Oligonucleotides (ASO) Therapy Market: Company Product Type Footprint
 Table 35. Antisense Oligonucleotides (ASO) Therapy Market: Company Product Application Footprint
 Table 36. Antisense Oligonucleotides (ASO) Therapy New Market Entrants and Barriers to Market Entry
 Table 37. Antisense Oligonucleotides (ASO) Therapy Mergers, Acquisition, Agreements, and Collaborations
 Table 38. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value (USD Million) by Type (2019-2024)
 Table 39. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Share by Type (2019-2024)
 Table 40. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Forecast by Type (2025-2030)
 Table 41. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2024)
 Table 42. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Forecast by Application (2025-2030)
 Table 43. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 44. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 45. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 46. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 47. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 48. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 49. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 50. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 51. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 52. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 53. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 54. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 55. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 56. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 57. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 58. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 59. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 60. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 61. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 62. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 63. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 64. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 65. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 66. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 67. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 68. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 69. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 70. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 71. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 72. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 73. Global Key Players of Antisense Oligonucleotides (ASO) Therapy Upstream (Raw Materials)
 Table 74. Global Antisense Oligonucleotides (ASO) Therapy Typical Customers


List of Figures
 Figure 1. Antisense Oligonucleotides (ASO) Therapy Picture
 Figure 2. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Type in 2023
 Figure 4. Intrathecal Injection
 Figure 5. Intravenous Injections
 Figure 6. Other
 Figure 7. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Application in 2023
 Figure 9. Neuromuscular Diseases Picture
 Figure 10. hATTR Picture
 Figure 11. Other Picture
 Figure 12. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 13. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 14. Global Market Antisense Oligonucleotides (ASO) Therapy Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 15. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 16. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Region in 2023
 Figure 17. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. Company Three Recent Developments and Future Plans
 Figure 23. Global Antisense Oligonucleotides (ASO) Therapy Revenue Share by Players in 2023
 Figure 24. Antisense Oligonucleotides (ASO) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 25. Market Share of Antisense Oligonucleotides (ASO) Therapy by Player Revenue in 2023
 Figure 26. Top 3 Antisense Oligonucleotides (ASO) Therapy Players Market Share in 2023
 Figure 27. Top 6 Antisense Oligonucleotides (ASO) Therapy Players Market Share in 2023
 Figure 28. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Share by Type (2019-2024)
 Figure 29. Global Antisense Oligonucleotides (ASO) Therapy Market Share Forecast by Type (2025-2030)
 Figure 30. Global Antisense Oligonucleotides (ASO) Therapy Consumption Value Share by Application (2019-2024)
 Figure 31. Global Antisense Oligonucleotides (ASO) Therapy Market Share Forecast by Application (2025-2030)
 Figure 32. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 33. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 34. North America Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 35. United States Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 36. Canada Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 37. Mexico Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 38. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 39. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 40. Europe Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 41. Germany Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 42. France Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 43. United Kingdom Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 44. Russia Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 45. Italy Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 46. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 47. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 48. Asia-Pacific Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 49. China Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 50. Japan Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 51. South Korea Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 52. India Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 53. Southeast Asia Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 54. Australia Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 55. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 56. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 57. South America Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 58. Brazil Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 59. Argentina Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 60. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 61. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Application (2019-2030)
 Figure 62. Middle East & Africa Antisense Oligonucleotides (ASO) Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 63. Turkey Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 64. Saudi Arabia Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 65. UAE Antisense Oligonucleotides (ASO) Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 66. Antisense Oligonucleotides (ASO) Therapy Market Drivers
 Figure 67. Antisense Oligonucleotides (ASO) Therapy Market Restraints
 Figure 68. Antisense Oligonucleotides (ASO) Therapy Market Trends
 Figure 69. Porters Five Forces Analysis
 Figure 70. Antisense Oligonucleotides (ASO) Therapy Industrial Chain
 Figure 71. Methodology
 Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Ionis Pharmaceuticals
Biogen
Sobi
Nippon Shinyaku
Jazz Pharmaceuticals

Related Reports

Global Antisense Oligonucleotides (ASO) Therapy Supply, Demand and Key Producers, 2024-2030

Global Antisense Oligonucleotides (ASO) Therapy Supply, Demand and Key Producers, 2024-2030

date 14 May 2024

date Pharma & Healthcare

Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases

Product Tags

Antisense Oligonucleotides (ASO) Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>